Radiology - imaging of stomach tumours , benign and malignant classification ,tnm staging, advance gastric cancer vs early gastric cancer, normal periganstric anatomy, ligament and stomach bed , all carcinoma mimics - minetriers, ZES, gastritis , lymphnode station, pet negative tumours and all pet negative pathology ,gist malignant and benign , lymphoma,lugano classification ,dowson criteria , glomus tumour, paraganglinoma ,swarnima ,lipoma ,liomyoma , ectopic pancreatic tissue in stomach,mets , give all possible dd and it's differentiating features with pathognomic imaging features

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Searching the Web

gastric lymphoma Lugano classification Dawson criteria imaging radiology 2024

Here is the full comprehensive reference document on gastric tumour radiology, synthesized from Grainger & Allison's Diagnostic Radiology, Yamada's Gastroenterology, and current classification systems:

Gastric Tumours: Complete Radiology Reference


1. NORMAL PERIGASTRIC ANATOMY

Stomach on Imaging

On CT (water distension protocol - 6-8 cups before scan), normal gastric wall = <5 mm when well distended. On barium double-contrast studies:
  • Areae gastricae: fine reticular network of mucosal tufts separated by sulci (2-3 mm antrum, 3-5 mm body/fundus) - seen in ~70% patients
  • Gastric rugae: smooth folds 3-5 mm thick, parallel to long axis, comprise mucosa + submucosa

Perigastric Ligaments & Stomach Bed

LigamentContentsConnections
Gastrohepatic (lesser omentum)Left gastric vessels, aberrant left hepatic arteryLesser curvature → porta hepatis
GastrocolicRight/left gastroepiploic vesselsGreater curvature → transverse colon
GastrosplenicShort gastric vessels, left gastroepiploicGreater curvature → splenic hilum
GastrophrenicShort gastric vessels (superior)Fundus → diaphragm
Stomach Bed (posterior wall relations on CT - critical for T4b staging):
  • Pancreatic body/tail (most important)
  • Left kidney and left adrenal
  • Splenic vessels and spleen
  • Transverse mesocolon
  • Left crus of diaphragm

Lymph Node Stations (Japanese Gastric Cancer Association)

StationLocationD-level
1Right paracardialD1
2Left paracardialD1
3Lesser curvature (left gastric territory)D1
4sa/4sb/4dGreater curvature (short gastric / gastroepiploic)D1
5SuprapyloricD1
6InfrapyloricD1
7Along left gastric arteryD2
8aAlong common hepatic artery (anterior)D2
9Along celiac axisD2
10Splenic hilumD2
11p/11dAlong proximal/distal splenic arteryD2
12aHepatoduodenal ligamentD2
13-16Retropancreatic, SMA, para-aorticDistant (M1)
D1 = stations 1-6 | D2 = stations 1-11 (standard curative) | Para-aortic = M1 disease
CT criterion for abnormal node: >8 mm short-axis diameter in perigastric region. Rim enhancement or central necrosis = malignant regardless of size.

2. GASTRIC CARCINOMA

90-95% of all malignant gastric tumours. Peak age 50-70 years. Distributed: ~one-third each in antrum, body, fundus-cardia; 10% diffusely infiltrative. Risk factors: H. pylori, chronic atrophic gastritis, autoimmune gastritis, polyposis syndromes.
Lauren Classification:
  • Intestinal type: gland-forming, H. pylori-associated, better prognosis, FDG-avid
  • Diffuse type (signet ring): no gland formation, infiltrates wall, linitis plastica, FDG-negative
  • Mixed

3. EARLY GASTRIC CANCER (EGC)

Definition: Carcinoma confined to mucosa (T1a) or submucosa (T1b), regardless of lymph node status. Originates from the Japanese screening program.

Japanese Morphological Classification:

TypeMorphology
IPolypoid, protrudes >5 mm into lumen
IIaSuperficial elevated, <5 mm
IIbFlat
IIcSuperficial depressed (most common; highest risk of LN mets)
IIIExcavated/ulcerated
IVLateral spreading

CT Features (MDCT):

  • Focal thickening of the inner mucosal layer only
  • Abnormal focal mucosal hyperenhancement on arterial phase
  • Preservation of outer hypodense stripe (submucosa) - the key T1 sign
  • Clear perigastric fat plane
  • T1 lesions without thickening are extremely difficult to detect; surface-shaded display or virtual gastroscopy (VG) may demonstrate them
  • EUS is superior to CT for T1/T2 distinction

4. ADVANCED GASTRIC CANCER (AGC)

Definition: Invades muscularis propria (T2) or beyond. Most common presentation in Western countries.

Borrmann Classification:

TypeDescriptionPrognosis
IPolypoid, sharply demarcatedBest
IIUlcerated, sharply demarcatedGood
IIIUlcerated, infiltrating marginsIntermediate
IVDiffusely infiltrating (linitis plastica)Worst
VUnclassifiable

CT Features:

  • Polypoid: irregular mass; shelf sign (acute angle to wall = mucosal origin)
  • Ulcerative: malignant ulcer sits WITHIN the gastric wall/mass (not projecting beyond wall); irregular nodular fold convergence (clubbed, amputated); no Hampton's line
  • Linitis plastica (scirrhous/Borrmann IV): diffuse thickening, loss of rugae, rigid non-distensible "leather bottle" stomach, perigastric fat stranding
  • Antral carcinoma: may cause gastric outlet obstruction

Benign vs Malignant Ulcer:

FeatureBenignMalignant
PositionProjects beyond wall outlineWithin wall/mass
MarginSmooth haloIrregular, nodular
Fold convergenceSmooth, tapersClubbed, nodular, amputated
Hampton's linePresentAbsent
Carman meniscus signAbsentPresent (en face)
Adjacent massNonePresent
DistensibilityNormalRigid

5. TNM STAGING (AJCC 8th Edition)

T Stage:

TDefinition
T1aLamina propria / muscularis mucosae
T1bSubmucosa
T2Muscularis propria
T3Subserosa (no serosal penetration)
T4aSerosa (visceral peritoneum) penetrated
T4bAdjacent organs (pancreas, spleen, colon, liver, diaphragm, kidney, adrenal, small bowel, retroperitoneum)

N Stage:

NRegional Nodes
N0None
N11-2 nodes
N23-6 nodes
N3a7-15 nodes
N3b≥16 nodes

M Stage:

  • M1 = any distant mets (liver first, then peritoneum, lung, adrenal, bone, Krukenberg ovary)
  • Positive peritoneal cytology = M1
  • Para-aortic nodal disease = M1

Imaging by Stage:

ModalityOptimal UseNotes
EUST1-T2 distinction65-92% accuracy; poor for T3/T4
MDCT (triphasic)Overall staging (T3+, N, M)Gold standard; water oral contrast
MRILiver mets, equivocal CTLimited T1/T2 discrimination
FDG-PET/CTDistant M staging, N3, responseUnreliable for N1/N2 (too close to primary)
Diagnostic laparoscopyPeritoneal metsHighest sensitivity for peritoneal disease
CT Protocol: Oral water (negative contrast), IV contrast arterial + portal venous phases, MPR coronal and sagittal, adequate gastric distension required.
Perigastric Fat Plane Assessment:
  • T3: haziness/stranding in fat; outer wall irregular
  • T4a: serosal nodularity; loss of outer definition
  • T4b: loss of fat plane + adjacent organ deformity

6. PET-NEGATIVE TUMOURS & PATHOLOGY

Gastric Carcinoma Subtypes That Are PET-Negative:

  1. Mucinous adenocarcinoma - mucin lakes with sparse metabolically active cells
  2. Signet ring cell carcinoma - poorly differentiated, discohesive, low metabolic density
  3. Poorly differentiated adenocarcinoma
  4. Diffuse type (Lauren) overall
  5. Low-grade MALToma

PET Limitations in Gastric Cancer (from Grainger & Allison):

  1. Intense variable physiological uptake in normal gastric wall (masks small primaries)
  2. Poor spatial resolution for N1/N2 (perigastric nodes too close to primary)
  3. Better for N3 distant nodes (high specificity)
  4. Metabolic response in FDG-avid tumours identifies therapy responders earlier than morphology

Other PET-Negative Gastric Pathologies:

EntityReasonAlternative
Well-differentiated NET/Carcinoid (G1)Low proliferation indexGa-68 DOTATATE PET
GIST (low-risk, small)Low mitotic rateCT (Choi criteria)
LipomaNo metabolic activityCT (fat density)
LeiomyomaBenignCT/MRI morphology
Ectopic pancreatic tissueNormal tissueEUS + CT morphology
Mucinous peritoneal metsAcellular mucin poolsCT/MRI
Low-grade MALTomaIndolentCT, endoscopy
Lobular breast metsSignet-ring-like, low avidityClinical history

7. MESENCHYMAL TUMOURS

GIST (Gastrointestinal Stromal Tumour)

Pathognomonic marker: CD117 (c-KIT) positive; DOG-1 positive; CD34 positive (70%). Arises from interstitial cells of Cajal.
Most common non-epithelial GI tumour. Location: stomach 60-70%, small bowel 20-30%.
CT (method of choice):
  • Submucosal/extraluminal (exophytic) growth pattern
  • Small tumours: homogeneous, well-defined, uniform enhancement
  • Large/malignant tumours: heterogeneous, central necrosis/haemorrhage/cystic change
  • Ulceration of overlying mucosa ("rose-thorn" or endoluminal niche)
  • No lymph node metastasis (key feature - distinguishes from carcinoma and lymphoma)
  • Liver mets (haematogenous) and peritoneal spread - NO lymph node spread
  • Pseudo-progression on imatinib (tumours become cystic/hypoattenuating) - use Choi criteria (density decrease >15% OR size >10%), not RECIST
Risk Stratification (Miettinen):
RiskSizeMitoses (/50 HPF)Gastric
Very low<2 cm<5Yes
Low2-5 cm<5Yes
Intermediate<5 cm, 6-10 mitOR 5-10 cm, <5 mitYes
High>10 cm any; OR >5 cm >5 mit; OR >10 mit any sizeYes
Malignant GIST features on CT: size >5 cm, irregular margins, heterogeneous enhancement, central necrosis, adjacent structure infiltration, liver/peritoneal mets.

Gastric Lipoma

  • Pathognomonic: Fat-density mass (HU -80 to -120) with thin capsule
  • Most common in antrum (submucosal location)
  • MRI: T1 bright, T2 bright, suppresses on fat saturation
  • Compressible on fluoroscopy
  • Benign; no malignant potential

Leiomyoma

  • Smooth muscle tumour from muscularis propria or muscularis mucosae
  • Most common at cardia / gastroesophageal junction
  • CT: homogeneous, well-defined, mild-moderate enhancement; calcification ~10%
  • CD117 negative, desmin/SMA positive - unlike GIST
  • Smaller, no exophytic growth tendency, no necrosis

Glomus Tumour

  • Extremely rare benign vascular tumour of modified smooth muscle (glomus body cells)
  • Occurs almost exclusively in antrum (submucosal)
  • CT pathognomonic feature: Intensely hypervascular, homogeneous, arterial phase enhancement (equal to or exceeding aorta)
  • MRI: T2 very high signal, avid gadolinium enhancement
  • Key differentiator from carcinoid: even more intensely vascular, more homogeneous

Paraganglioma

  • Extra-adrenal chromaffin cell tumour; gastric location extremely rare
  • MRI pathognomonic: "Salt and pepper" appearance on T2 (flow voids = pepper; haemorrhagic foci = salt)
  • CT: hypervascular mass, intense arterial enhancement
  • Ga-68 DOTATATE PET positive
  • Malignancy only determined by metastatic spread, not histology

Schwannoma

  • Rare; most common benign gastric neurogenic tumour
  • CT: well-defined homogeneous submucosal mass; peripheral lymph node cuff is characteristic
  • S100 positive, CD117 negative, CD34 negative

8. GASTRIC LYMPHOMA

The stomach is the most common site of primary GI lymphoma (>70%). Almost exclusively NHL.
Subtypes:
  • Low-grade MALToma: H. pylori-associated (CagA protein), indolent; may regress with H. pylori eradication alone
  • DLBCL: High-grade; may arise de novo or from MALToma transformation; aggressive

Imaging Features:

  • CT: Diffuse or segmental mural thickening (often >2 cm), preserved perigastric fat planes (key differentiator)
  • Homogeneous enhancement; bulky regional adenopathy
  • Can cross the pylorus (unlike carcinoma which tends to respect it)
  • Multiple submucosal nodules, ulcerations, polypoid masses on barium

Lymphoma vs Carcinoma on CT:

FeatureLymphomaCarcinoma
Fat planesPreservedObliterated (advanced)
EnhancementHomogeneousHeterogeneous
Wall thicknessOften >2 cmVariable
Pylorus crossingYesNo
Nodal patternBulky, homogeneousHeterogeneous, smaller
PeristalsisPreserved longerRigid early

Dawson Criteria (Primary GI Lymphoma):

  1. No peripheral lymphadenopathy at presentation
  2. No mediastinal lymphadenopathy
  3. Normal WBC and differential on peripheral blood
  4. Predominantly bowel involvement with regional nodes only
  5. No hepatic or splenic involvement (except by direct extension)

Lugano Classification (GI Lymphoma Staging):

StageExtent
IConfined to GI tract (single or multiple non-contiguous)
II1Extending into abdomen with local node involvement
II2Extending with distant abdominal nodes
IIESerosa penetrated; adjacent organ involved
IVDisseminated extranodal or supradiaphragmatic nodal involvement

Lugano 5-Point Deauville Scale (PET Response):

ScoreFDG uptakeInterpretation
1No uptakeComplete metabolic response
2≤ mediastinumComplete metabolic response
3> mediastinum, ≤ liverAdequate response (context-dependent)
4Moderately > liverIncomplete response
5Markedly > liver OR new lesionsIncomplete/progressive
FDG-PET/CT is the gold standard for staging FDG-avid histologies (DLBCL, Hodgkin's). MALToma is variably avid - stage with CT.

9. CARCINOID / NEUROENDOCRINE TUMOUR (NET)

TypeAssociationFeatures
Type 1Chronic atrophic gastritis / pernicious anaemiaMultiple small (<1 cm), ECL cell, low malignant potential
Type 2ZES / MEN-1Multiple, ECL cell, moderate risk
Type 3SporadicSolitary, large, aggressive, liver mets common
  • CT: small hypervascular submucosal nodules (Types 1/2); large single mass (Type 3)
  • Ga-68 DOTATATE PET is the modality of choice - FDG negative (G1/G2)
  • G3 neuroendocrine carcinoma (NEC): FDG-positive

10. CARCINOMA MIMICS

Ménétrier's Disease

  • Foveolar cell hyperplasia, protein-losing enteropathy
  • Barium/CT: Massively enlarged, bizarre lobulated folds - proximal stomach and greater curvature, classic antral sparing (antrum involved up to 50%)
  • Folds remain pliable - key differentiator (carcinoma = rigid, aperistaltic)
  • Increased small bowel fluid (protein-losing)
  • Fibrosing variant mimics linitis plastica

Zollinger-Ellison Syndrome (ZES)

  • Gastrinomas (75% pancreas, 15% duodenum); 50% malignant with liver mets
  • Gastric imaging: Thickened folds + excess gastric secretions, multiple peptic ulcers (distal duodenum/jejunum - 4th part)
  • CT: hypervascular pancreatic/duodenal mass; gastrinoma triangle
  • Associated with MEN-1
  • Ga-68 DOTATATE PET / Octreotide scan for tumour detection

Eosinophilic Gastritis

  • Diffuse eosinophil infiltration in atopic/asthmatic patients
  • CT: diffuse wall thickening, antral narrowing and rigidity, mucosal nodularity
  • Eosinophilic ascites (serosal involvement)
  • Peripheral eosinophilia

Amyloidosis

  • Submucosal amyloid deposition
  • CT: diffuse wall thickening, rigidity - mimics linitis plastica
  • Non-specific; diagnosis by biopsy (Congo red staining, apple-green birefringence)

Corrosive Gastritis

  • Acid ingestion: necrosis → fibrosis
  • CT/barium late: severely deformed, contracted stomach ("tobacco pouch"), luminal narrowing down to duodenal bulb size

Gastric Varices

  • Fundal submucosal nodular/serpiginous masses ("grape-like")
  • CT/MRI: enhancing submucosal vessels on venous phase
  • Efface with compression (pliable) - differentiates from neoplasm
  • Portal hypertension context; absent oesophageal varices + gastric varices alone = splenic vein thrombosis (pancreatitis/pancreatic Ca)

11. ECTOPIC PANCREATIC TISSUE

  • Most common site: Antrum/pylorus, greater curvature, submucosal
  • Pathognomonic barium/endoscopy finding: Submucosal mass with central umbilication (represents the ductal orifice)
  • CT: isoattenuating to normal pancreas, ill-defined or well-defined, duct-like structure may be visible
  • MRI: same signal characteristics as normal pancreatic tissue on all sequences
  • Benign; rarely complicated by pancreatitis within the rest

12. GASTRIC METASTASES

PrimaryPatternKey Feature
MelanomaMultiple "bull's-eye" lesionsCentral ulceration in submucosal mass
Lobular breast CaLinitis plasticaDiffuse wall thickening, rigid; ER/PR+
LungSubmucosal massesUsually small, asymptomatic
Kaposi sarcomaSubmucosal haemorrhagic lesionsHIV context
Ovary (Krukenberg)Bilateral ovarian masses + gastric primarySignet ring cells

13. COMPLETE DIFFERENTIAL DIAGNOSIS WITH DIFFERENTIATING FEATURES

EntityCT AppearancePathognomonic FeaturePET Avidity
Adenocarcinoma (intestinal)Irregular mural thickening, fat plane lossShelf sign, mucosal originPositive
Diffuse Ca / Linitis plasticaRigid non-distensible stomachLeather bottle, no areae gastricaeNegative/low
MALTomaThickened folds, fat plane preservedCrosses pylorus, H. pylori+Variable (often -)
DLBCLBulky polypoid/infiltratingPreserved fat plane, homogeneousPositive
GISTExophytic submucosal, central necrosisNO lymph nodes, CD117+, pseudocystLow/variable
LipomaFat density (-80 to -120 HU)Fat density + thin capsule (pathognomonic)Negative
LeiomyomaIntramural, homogeneous, GEJCD117-, no exophytic, calcificationNegative
Carcinoid/NETHypervascular submucosal nodulesGa-68 DOTATATE positiveNegative (G1/2)
Glomus tumourHypervascular antral submucosalIntense arterial enhancement (= aorta)Variable
ParagangliomaHypervascular, extra-adrenalSalt-and-pepper T2 MRI, DOTATATE+Variable
SchwannomaHomogeneous, peripheral nodal cuffS100+, CD117-, peripheral nodesNegative
Ménétrier'sMassive pliable folds, antral sparingPliable (not rigid), protein-losingNegative
ZESThickened folds + excess secretionsMultiple distal PUD, pancreatic massDOTATATE+
Ectopic pancreasAntral submucosal massCentral umbilication (ductal orifice)Negative
Gastric varicesFundal serpiginous submucosalVenous enhancement, pliableNegative
Melanoma metsMultiple submucosal massesBull's-eye (central ulceration)Variable
Breast lobular metsLinitis plasticaHistory, ER/PR+, bilateral ovaryNegative/low
Eosinophilic gastritisAntral rigidity, wall thickeningPeripheral eosinophilia, atopicNegative
AmyloidosisDiffuse rigidityCongo red biopsyNegative
Corrosive gastritisDeformed contracted stomachHistory of ingestionNegative

14. QUICK REFERENCE: PATHOGNOMONIC IMAGING SIGNS

SignDiagnosis
Leather bottle / non-distensible stomachLinitis plastica (diffuse Ca, breast lobular mets)
Preserved fat plane + bulky nodesLymphoma favoured over carcinoma
Central umbilication in antral submucosal massEctopic pancreatic tissue
Bull's-eye lesion (submucosal + central ulcer)Melanoma mets (also GIST)
Fat density (-HU) with thin capsuleGastric lipoma
Massive pliable folds, antral sparingMénétrier's disease
Exophytic mass, no lymph nodesGIST
Intense arterial enhancement (= aorta)Glomus tumour
Salt and pepper T2 MRIParaganglioma
Outer hypodense stripe preserved on CTEGC (T1 confined)
Hampton's lineBenign peptic ulcer
Carman meniscus signMalignant gastric ulcer (en face)
Multiple hypervascular submucosal nodulesCarcinoid/NET Type 1 or 2
Lymphoma crossing pylorusGastric lymphoma (carcinoma rarely does this)
Pseudo-progression/cystic change on imatinibGIST response (use Choi, not RECIST)

Sourced from: Grainger & Allison's Diagnostic Radiology 6e (Chapter 20); Yamada's Textbook of Gastroenterology 7e; Sleisenger & Fordtran's GI & Liver Disease; AJCC 8th Edition TNM; Lugano Classification (Cheson et al. 2014); Japanese Gastric Cancer Association Guidelines
This is a shared conversation. Sign in to Orris to start your own chat.